Kumar, S;
Lockwood, N;
Ramel, MC;
Correia, T;
Ellis, M;
Alexandrov, Y;
Andrews, N;
... French, P; + view all
(2016)
Quantitative in vivo optical tomography of cancer progression & vasculature development in adult zebrafish.
Oncotarget
, 7
(28)
pp. 43939-43948.
10.18632/oncotarget.9756.
Preview |
Text
Kumar et al 2016 Quantitative in vivo optical tomography.pdf Download (4MB) | Preview |
Preview |
Text
Kumar et al 2016 Quantitative in vivo optical tomography Supplementary information.pdf Download (4MB) | Preview |
![[thumbnail of Kumar et al 2016 Quantitative in vivo optical tomography video 1.mp4]](https://discovery.ucl.ac.uk/style/images/fileicons/video.png) |
Video
Kumar et al 2016 Quantitative in vivo optical tomography video 1.mp4 Download (8MB) |
|
Video
Kumar et al 2016 Quantitative in vivo optical tomography video 2.mp4 Download (7MB) |
|
Video
Kumar et al 2016 Quantitative in vivo optical tomography video 3.mp4 Download (3MB) |
|
Video
Kumar et al 2016 Quantitative in vivo optical tomography video 4.mp4 Download (7MB) |
Abstract
We describe a novel approach to study tumour progression and vasculature development in vivo via global 3-D fluorescence imaging of live non-pigmented adult zebrafish utilising angularly multiplexed optical projection tomography with compressive sensing (CS-OPT). This “mesoscopic” imaging method bridges a gap between established ~µm resolution 3-D fluorescence microscopy techniques and ~mm-resolved whole body planar imaging and diffuse tomography. Implementing angular multiplexing with CS-OPT, we demonstrate the in vivo global imaging of an inducible fluorescently labelled genetic model of liver cancer in adult non-pigmented zebrafish that also present fluorescently labelled vasculature. In this disease model, addition of a chemical inducer (doxycycline) drives expression of eGFP tagged oncogenic K-RASV12 in the liver of immune competent animals. We show that our novel in vivo global imaging methodology enables non-invasive quantitative imaging of the development of tumour and vasculature throughout the progression of the disease, which we have validated against established 2 methods of pathology including immunohistochemistry. We have also demonstrated its potential for longitudinal imaging through a study of vascular development in the same zebrafish from early embryo to adulthood. We believe that this instrument, together with its associated analysis and data management tools, constitute a new platform for in vivo cancer studies and drug discovery in zebrafish disease models.
Archive Staff Only
 |
View Item |
